Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$43.4M | -$69.0M | -$93.4M | -$126M | -$121M | -$372M |
| Net income | -$43.3M | -$68.9M | -$92.1M | -$118M | -$117M | -$696M |
| EPS (diluted) | -$230.57 | -$2.10 | -$2.33 | -$1.75 | -$34.03 | -$70.50 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$36.3M | -$69.1M | -$85.1M | -$100M | -$99.7M | -$143M |
| Capital expenditures | $4.16M | $3.89M | $8.46M | $1.07M | $229K | $941K |
| Free cash flow | -$40.5M | -$73.0M | -$93.6M | -$101M | -$99.9M | -$144M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $48.5M | $120M | $57.7M | $31.4M | $81.9M | $396M |
| Total assets | $75.9M | $243M | $299M | $198M | $143M | $464M |
| Total liabilities | $27.6M | $26.3M | $48.8M | $47.4M | $46.2M | $628M |
| Shareholders' equity | -$59.1M | $216M | $251M | $151M | $96.7M | -$164M |
| Retained earnings | -$61.2M | -$130M | -$222M | -$340M | -$457M | -$1.15B |
| Shares (wtd avg diluted) | 505K | 33.4M | 39.6M | 67.2M | 3.44M | 9.87M |
Every figure is extracted from Vor Biopharma Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.